Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.5%

5 terminated out of 37 trials

Success Rate

81.5%

-5.0% vs benchmark

Late-Stage Pipeline

14%

5 trials in Phase 3/4

Results Transparency

27%

6 of 22 completed with results

Key Signals

6 with results81% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (11)
Early P 1 (1)
P 1 (4)
P 2 (8)
P 3 (2)
P 4 (3)

Trial Status

Completed22
Terminated5
Unknown5
Active Not Recruiting2
Recruiting1
Withdrawn1

Trial Success Rate

81.5%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT04267861Active Not Recruiting

M7824 Related Adverse Effects in Adults With Cancer

NCT00001813Completed

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

NCT07524062Not ApplicableNot Yet Recruiting

The Application of Infrared Thermography in the Prediction of Skin Healing in Surgery

NCT06295809Phase 2Completed

A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)

NCT07404605Not ApplicableRecruiting

Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma

NCT07415291Active Not Recruiting

CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis

NCT02836548Phase 1Completed

HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma

NCT04630886Early Phase 1TerminatedPrimary

Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery

NCT03012581Phase 2Completed

Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types

NCT05359419Phase 4UnknownPrimary

Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities

NCT00847912Phase 4Completed

CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial

NCT02310503CompletedPrimary

Spanish Registry of Mohs Surgery

NCT02705352Phase 2Completed

5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts

NCT04251598Not ApplicableCompletedPrimary

I am Protecting my Child From the Sun Program

NCT00204789Phase 2Completed

Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients

NCT00993512Phase 1Completed

Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer

NCT02900248Terminated

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

NCT02813902Phase 1Withdrawn

A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors

NCT02303041Phase 2Terminated

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

NCT00027586Phase 2Completed

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Scroll to load more

Research Network

Activity Timeline